Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$4.41 USD

4.41
8,665,192

-0.41 (-8.51%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $4.42 +0.01 (0.23%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Canopy Growth (CGC) to Report Q2 Earnings: What's in Store?

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in fiscal second quarter.

Trina Mukherjee headshot

3 Medical Product Stocks Poised to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, on the back of several factors.

Neena Mishra headshot

Why Cannabis Stocks & ETFs Are Soaring

Marijuana stocks are rising on hopes of favorable regulatory environment

Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in Pharmaceutical segment.

What's in Store for Becton, Dickinson's (BDX) Q4 Earnings?

Becton, Dickinson's (BDX) fiscal fourth-quarter results likely to reflect robust performance at BD Life Sciences.

Humana (HUM) Gears Up for Q3 Earnings: What Awaits the Stock?

Humana's (HUM) third-quarter 2020 results are likely to reflect elevated expenses and lower net investment income, partially offset by a growing membership base.

Universal Health (UHS) to Report Q3 Results: What to Expect

Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.

Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues

Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.

Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?

Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.

Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y

Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

Tracey Ryniec headshot

Is it Finally Time to Buy Marijuana Stocks?

With new states set to legalize cannabis this November, and the possibility of federal legalization looming, will the marijuana stocks finally live up to the hype?

Canopy Growth (CGC) Looks Good: Stock Adds 8.5% in Session

Canopy Growth (CGC) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Sanghamitra Saha headshot

Here's How to Play a Likely Biden Win

Per an ABC News/Washington Post national poll released on Oct 11, Biden has a lead over Trump by 12 percentage points nationally.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Canopy Growth Corporation (CGC) closed at $14.20, marking a -0.84% move from the previous day.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $14.17, moving -0.7% from the previous trading session.

Canopy Growth Corporation (CGC) Stock Moves -0.24%: What You Should Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $16.36, moving -0.24% from the previous trading session.

Implied Volatility Surging for Canopy Growth (CGC) Stock Options

Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.

Company News for Aug 11, 2020

Companies In The News Are: CGC, GOLD, RCL, MAR.

Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates

Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of 28.57% and 16.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products Stock Earnings on Aug 10: CGC, SDGR & More

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

Canopy Growth Corporation (CGC) closed at $19.21 in the latest trading session, marking a -0.57% move from the prior day.

Analysts Estimate Canopy Growth Corporation (CGC) to Report a Decline in Earnings: What to Look Out for

Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth (CGC) to Report Q1 Earnings: What's in Store?

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal first quarter.

Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $18.60, moving +0.59% from the previous trading session.